|
GNA12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.585700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.770800E-04 |
| Normal-vs-Stage2 |
1.308220E-02 |
| Normal-vs-Stage3 |
1.697050E-03 |
| Normal-vs-Stage4 |
3.383000E-04 |
| Stage1-vs-Stage2 |
8.226000E-01 |
| Stage1-vs-Stage3 |
9.617200E-01 |
| Stage1-vs-Stage4 |
3.575200E-01 |
| Stage2-vs-Stage3 |
8.809200E-01 |
| Stage2-vs-Stage4 |
4.035200E-01 |
| Stage3-vs-Stage4 |
4.403000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.952800E-04 |
| Normal-vs-AfricanAmerican |
6.596200E-02 |
| Normal-vs-Asian |
1.904310E-02 |
| Caucasian-vs-AfricanAmerican |
4.941000E-01 |
| Caucasian-vs-Asian |
8.814000E-01 |
| AfricanAmerican-vs-Asian |
7.195400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.825500E-04 |
| Normal-vs-Female |
3.398200E-04 |
| Male-vs-Female |
8.153000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.699900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.204250E-04 |
| Normal-vs-Age(61-80Yrs) |
7.020100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.511000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.852400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.745800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.499800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.928600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.071200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.020000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.436000E-01 |
| Classical-VS-Follicular |
1.90850000025833E-07 |
| Classical-VS-Other |
1.057590E-01 |
| Classical-VS-Normal |
1.544400E-02 |
| Tall-VS-Follicular |
1.420030E-02 |
| Tall-VS-Other |
2.837400E-01 |
| Tall-VS-Normal |
4.998500E-02 |
| Follicular-VS-Other |
9.396800E-01 |
| Follicular-VS-Normal |
7.88370002613448E-09 |
| Other-VS-Normal |
7.997900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.93460000000357E-05 |
| Normal-vs-N1 |
8.12440000000914E-05 |
| N0-vs-N1 |
2.883600E-01 |
|
|
